leading glp-1 treatments for diabetes 2025 Puerto Rico leads U.S. growth in prescriptions in top glp-1 drugs for type

J Chin Med Assoc

Noom releases a significant update of its innovative GLP-1 companion to improve medication persistence and adherence while decreasing side effect prevalence and improving lean mass preservation and weight loss outcomes

Do you have diabetes

This is a large, carefully designed observational study not a randomised trial so it points to a promising signal rather than a proven benefit

A variant in TCF7L2 , tied to glucose homeostasis and GLP-1 secretion, or in FTO , GLP1R , and MC4R , maps the metabolic terrain any GLP-1 compound acts on

Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes